Efficacy of low dose tamsulosin in medical expulsive therapy for ureteral stones in Japanese male patients: A randomized controlled studyInvestigation

International Journal of Urology

Volumn 17, Issue 5, 2010, Pages 462-465

  Kaneko, Tomoyuki ^a   Matsushima, Hisashi ^a   Morimoto, Hirohiko ^a   Tsuzaka, Yasuo ^a   Homma, Yukio ^b  

^a TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adrenergic alpha antagonists; Tamsulosin; Ureteral calculi

Indexed keywords

DICLOFENAC; TAMSULOSIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; URETER STONE; X RAY;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TREATMENT OUTCOME; URETERAL CALCULI;

EID: 77951261359     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02499.x     Document Type: Article

References (24)

1. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J. Nephrol. 2000 13 (Suppl 3 S45 50.
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003 63 : 1817 1823.
3. Hollingsworth JM, Rogers MA, Kaufman SR et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006 368 : 1171 1179.
4. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J. Urol. 1999 162 : 27 30.
5. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J. Urol. 2005 173 : 2010 2012.
6. Cervenakov I, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker - Tamsulosin. Int. Urol. Nephrol. 2002 34 : 25 9.
7. Parsons JK, Hergan LA, Sakamoto K, Lakin C. Efficacy of alpha-blockers for the treatment of ureteral stones. J. Urol. 2007 177 : 983 987 discussion 987.
8. Kupeli B, Irkilata L, Gurocak S et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 2004 64 : 1111 1115.
9. Resim S, Ekerbicer HC, Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 2005 66 : 945 948.
10. De Sio M, Autorino R, Di Lorenzo G et al. Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J. Endourol. 2006 20 : 12 16.
11. Pedro RN, Hinck B, Hendlin K, Feia K, Canales BK, Monga M. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J. Urol. 2008 179 : 2244 2247 discussion 7.
12. Wang CJ, Huang SW, Chang CH. Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones. J. Endourol. 2008 22 : 41 6.
13. Lojanapiwat B, Kochakarn W, Suparatchatpan N, Lertwuttichaikul K. Effectiveness of low-dose and standard-dose tamsulosin in the treatment of distal ureteric stones: a randomized controlled study. J. Int. Med. Res. 2008 36 : 529 536.
14. Kobayashi M, Naya Y, Kino M et al. Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int. J. Urol. 2008 15 : 495 498.
15. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001 357 : 1191 1194. (Pubitemid 32378696)
16. Ibrahim AI, Shetty SD, Awad RM, Patel KP. Prognostic factors in the conservative treatment of ureteric stones. Br. J. Urol. 1991 67 : 358 361.
17. Tzortzis V, Mamoulakis C, Rioja J, Gravas S, Michel MC, de la Rosette JJ. Medical expulsive therapy for distal ureteral stones. Drugs 2009 69 : 677 692.
18. Malin JM Jr., Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br. J. Urol. 1970 42 : 171 174.
19. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int. J. Urol. 2007 14 : 749 753.
20. Weiss RM, Bassett AL, Hoffman BF. Adrenergic innervation of the ureter. Invest. Urol. 1978 16 : 123 127.
21. Sun X, He L, Ge W, Lv J. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J. Urol. 2009 181 : 1716 1720.
22. Lotan Y, Gettman MT, Roehrborn CG, Cadeddu JA, Pearle MS. Management of ureteral calculi: a cost comparison and decision making analysis. J. Urol. 2002 167 : 1621 1629.
23. Daniels GF Jr., Garnett JE, Carter MF. Ureteroscopic results and complications: experience with 130 cases. J. Urol. 1988 139 : 710 713.
24. Bensalah K, Pearle M, Lotan Y. Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur. Urol. 2008 53 : 411 418.